These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7884826)

  • 61. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.
    Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N
    Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.
    Chen SH; Shine HD; Goodman JC; Grossman RG; Woo SL
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3054-7. PubMed ID: 8159705
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
    Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
    Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer.
    Chhikara M; Huang H; Vlachaki MT; Zhu X; Teh B; Chiu KJ; Woo S; Berner B; Smith EO; Oberg KC; Aguilar LK; Thompson TC; Butler EB; Aguilar-Cordova E
    Mol Ther; 2001 Apr; 3(4):536-42. PubMed ID: 11319915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
    Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.
    Cool V; Pirotte B; Gérard C; Dargent JL; Baudson N; Levivier M; Goldman S; Hildebrand J; Brotchi J; Velu T
    Hum Gene Ther; 1996 Mar; 7(5):627-35. PubMed ID: 8845388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging.
    Namba H; Iwadate Y; Tagawa M; Kimura M; Shimizu H; Sato Y; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1996 Oct; 7(15):1847-52. PubMed ID: 8894676
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
    Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
    Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
    Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome.
    Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
    Brain Res; 1995 Sep; 691(1-2):76-82. PubMed ID: 8590067
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
    Ram Z; Culver KW; Walbridge S; Frank JA; Blaese RM; Oldfield EH
    J Neurosurg; 1993 Sep; 79(3):400-7. PubMed ID: 8395592
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.
    Trask TW; Trask RP; Aguilar-Cordova E; Shine HD; Wyde PR; Goodman JC; Hamilton WJ; Rojas-Martinez A; Chen SH; Woo SL; Grossman RG
    Mol Ther; 2000 Feb; 1(2):195-203. PubMed ID: 10933931
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
    Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.
    Parsa AT; Chi JH; Hurley PT; Jeyapalan SA; Bruce JN
    Neurosurgery; 2001 Sep; 49(3):681-8; discussion 688-9. PubMed ID: 11523680
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
    Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir.
    Kim SH; Kim JH; Kolozsvary A; Brown SL; Freytag SO
    J Neurooncol; 1997 Jul; 33(3):189-94. PubMed ID: 9195489
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
    Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
    Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
    Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study.
    Harsh GR; Deisboeck TS; Louis DN; Hilton J; Colvin M; Silver JS; Qureshi NH; Kracher J; Finkelstein D; Chiocca EA; Hochberg FH
    J Neurosurg; 2000 May; 92(5):804-11. PubMed ID: 10794295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.